Pharma and healthcare stocks rose sharply on Thursday after a Wall Street Journal report suggested that the Trump administration may not impose tariffs on generic medicines. The news brought relief to investors and the sector, which had been under pressure following the announcement of 100% tariffs on branded and patented pharmaceutical products by the US government.
The report said that the move to exclude generic medicines from tariffs is not yet final but is being considered seriously.
Continue Reading on India Today
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.